Insider trades
Elizabeth Yeu Lin, Chief Officer of Tarsus Pharmaceuticals TARS, has filed 2 purchases and 5 sales on the open market. Over the past 12 months that comes to a net sale of $243.4K. The latest trade was on 03/19.
Elizabeth Yeu Lin
Chief Medical Officer
- Company
- Tarsus Pharmaceuticals TARS
- First filing
- 23/06/16
- Trades
- 33 trades
- Buys / sales
- 2 / 5
- 12-month net buying
- −$243.4K
- Last trade
- 03/19
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
TARS | Open-market sale | 03/17–03/19 | 03/19 | 1,144 sh3 trades | $68.36avg. | $78,203.59 | −4.7% |
| Open-market sale | 25/12/16 | 25/12/17 | 2,078 sh | $79.50 | $165,201 | −8.7% | |
| Open-market sale | 25/06/16 | 25/06/17 | 1,006 sh | $41.08 | $41,326.48 | −11.6% | |
Staar SurgicalSTAA | Open-market buy | 23/09/21 | 23/09/22 | 2,500 sh | $40.00 | $100,000 | +704.2% |
| Open-market buy | 23/08/15 | 23/08/17 | 9,506 sh | $16.80 | $159,700.8 | +149.5% |
